Galenika announces an innovative peptide platform

The company Galenika has announced a major innovation in the market – a peptide platform developed in collaboration with its sister pharmaceutical company, EMS from Brazil. This announcement was mentioned by the author of an article on new peptide-based medications for type 2 diabetes and obesity, published on the Telegraf.rs portal. 

You can read the full article here.